135 related articles for article (PubMed ID: 17666856)
21. Fabrication and evaluation of Eudragit
Chantasart D; Tocanitchart P; Wongrakpanich A; Teeranachaideekul V; Junyaprasert VB
Pharm Dev Technol; 2018 Oct; 23(8):771-779. PubMed ID: 28406344
[TBL] [Abstract][Full Text] [Related]
22. Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads.
Fan C; Pai-Thakur R; Phuapradit W; Zhang L; Tian H; Malick W; Shah N; Kislalioglu MS
Eur J Pharm Sci; 2009 Apr; 37(1):1-10. PubMed ID: 19027852
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the permeation and mechanical characteristics of some aqueous-based film coating systems.
Okhamafe AO; York P
J Pharm Pharmacol; 1983 Jul; 35(7):409-15. PubMed ID: 6136580
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
[TBL] [Abstract][Full Text] [Related]
25. Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets.
Vlachou M; Geraniou E; Siamidi A
Acta Pharm; 2020 Mar; 70(1):49-61. PubMed ID: 31677367
[TBL] [Abstract][Full Text] [Related]
26. New film forming emulsions containing Eudragit® NE and/or RS 30D for sustained dermal delivery of nonivamide.
Lunter DJ; Daniels R
Eur J Pharm Biopharm; 2012 Oct; 82(2):291-8. PubMed ID: 22750130
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization and pharmacokinetics evaluation of clarithromycin-loaded Eudragit(®) L-100 microspheres.
Xu J; Li W; Liu Z; Li J; Zhao X; Li D; Guo S; Zhang X
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):287-93. PubMed ID: 25652786
[TBL] [Abstract][Full Text] [Related]
28. Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions.
Beak IH; Kim MS
Chem Pharm Bull (Tokyo); 2012; 60(11):1468-73. PubMed ID: 23124571
[TBL] [Abstract][Full Text] [Related]
29. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
30. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
[TBL] [Abstract][Full Text] [Related]
31. Polymer blends used for the coating of multiparticulates: comparison of aqueous and organic coating techniques.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
Pharm Res; 2004 May; 21(5):882-90. PubMed ID: 15180349
[TBL] [Abstract][Full Text] [Related]
32. Polysaccharides as excipients for colon-specific coatings. Permeability and swelling properties of casted films.
Cavalcanti OA; Van den Mooter G; Caramico-Soares I; Kinget R
Drug Dev Ind Pharm; 2002; 28(2):157-64. PubMed ID: 11926360
[TBL] [Abstract][Full Text] [Related]
33. An investigation into moisture barrier film coating efficacy and its relevance to drug stability in solid dosage forms.
Mwesigwa E; Basit AW
Int J Pharm; 2016 Jan; 497(1-2):70-7. PubMed ID: 26551674
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
Ozaki S; Kushida I; Yamashita T; Hasebe T; Shirai O; Kano K
J Pharm Sci; 2013 Jul; 102(7):2273-81. PubMed ID: 23658029
[TBL] [Abstract][Full Text] [Related]
35. Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: The inclusion of hydrophilic additives to develop moisture-activated release systems.
Albarahmieh E; Qi S; Craig DQM
Int J Pharm; 2016 Nov; 514(1):270-281. PubMed ID: 27863672
[TBL] [Abstract][Full Text] [Related]
36. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
Sauer D; McGinity J
Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
[TBL] [Abstract][Full Text] [Related]
37. Correlation between the permeability of metoprolol tartrate through plasticized isolated ethylcellulose/hydroxypropyl methylcellulose films and drug release from reservoir pellets.
Ye ZW; Rombout P; Remon JP; Vervaet C; Van den Mooter G
Eur J Pharm Biopharm; 2007 Sep; 67(2):485-90. PubMed ID: 17383166
[TBL] [Abstract][Full Text] [Related]
38. Investigation of drug-polymer interaction in solid dispersions by vapour sorption methods.
Punčochová K; Heng JY; Beránek J; Stěpánek F
Int J Pharm; 2014 Jul; 469(1):159-67. PubMed ID: 24751346
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions.
Bando H; McGinity JW
Int J Pharm; 2006 Apr; 313(1-2):43-8. PubMed ID: 16487672
[TBL] [Abstract][Full Text] [Related]
40. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
